Journals
Publish with us
Publishing partnerships
About us
Blog
Case Reports in Endocrinology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Case Reports in Endocrinology
/
2019
/
Article
/
Fig 3
/
Case Report
Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma
Figure 3
Chest CT 6 months after start of pembrolizumab showing ongoing response.
